Table 2.
Cardiovascular risk factors at baseline, 1 year, and change over 1 year, total sample.
| n = 404 | Baseline mean (SD) |
1 year mean (SD) |
Change over 1 year mean (95% CI) |
p Value |
|---|---|---|---|---|
| Weight (kg) | 86.7 (18.7) | 84.5 (18.6) | −2.1 (−1.6 to −2.6)c | <0.001a |
| BMI (kg/m2) | 29.3 (5.5) | 28.6 (5.5) | −0.7 (−0.5 to −0.9)c | <0.001a |
| Waist circumference (cm) | 101.2 (13.7) | 98.2 (13.5) | −2.9 (−2.5 to −3.4) | <0.001a |
| Systolic BP (mmHg) | 149.2 (17.1) | 140.5 (15.4) | −8.7 (−7.1 to −10.4)c | <0.001a |
| Anti-hypertensive medication, n = 268 | 150.3 (18.1) | 139.3 (15.3) | −11.0 (−9.0 to −13.1)c | <0.001a |
| No medication, n = 136 | 147.0 (14.8) | 142.8 (15.5) | −4.2 (−1.7 to −6.8) | 0.001a |
| Diastolic BP (mmHg) | 88.0 (10.5) | 84.1 (8.8) | −4.0 (−3.0 to −4.9)c | <0.001a |
| Anti-hypertensive medication, n = 268 | 88.4 (11.1) | 83.3 (8.6) | −5.1 (−3.9 to −6.3) | <0.001a |
| No medication, n = 136 | 87.4 (9.3) | 85.5 (9.0) | −1.8 (−0.3 to −3.3)c | 0.017a |
| Total cholesterol (mmol/L) | 5.94 (1.18) | 5.72 (1.10) | −0.22 (−0.13 to −0.31) | <0.001a |
| With statin medication, n = 65 | 6.19 (1.63) | 5.22 (1.36) | −0.97 (−0.58 to −1.37) | <0.001a |
| No statin medication, n = 339 | 5.89 (1.06) | 5.81 (1.02) | −0.08 (0.00 to −0.15) | 0.051 |
| LDL (mmol/L) | 3.86 (0.99) | 3.72 (0.99) | −0.14 (−0.06 to −0.21) | <0.001a |
| With statin medication, n = 65 | 3.89 (1.32) | 3.21 (1.19) | −0.68 (−0.38 to −0.98) | <0.001a |
| No statin medication, n = 339 | 3.86 (0.92) | 3.82 (0.91) | −0.04 (−0.03 to 0.10) | 0.249 |
| HDL (mmol/L) | 1.37 (0.37) | 1.40 (0.38) | 0.04 (0.02 to 0.05)c | <0.001a |
| Triglycerides (mmol/L) | 1.66 (1.06) | 1.51 (0.82) | −0.15 (−0.08 to −0.23)b,c | 0.001a |
| Fasting plasma glucose (mmol), n = 109 | 8.51 (2.99) | 7.15 (1.70) | −1.36 (−0.85 to −1.88) | <0.001a |
| Glucose-lowering medication, n = 42 | 10.17 (3.75) | 7.85 (1.92) | −2.32 (−1.19 to −3.46) | <0.001a |
| No medication, n = 67 | 7.48 (1.75) | 6.72 (1.39) | −0.76 (−0.35 to −1.17) | <0.001a |
Values are presented as mean (SD) for baseline and 1-year measurements, and as mean (95% CI) for change over 1 year.
aSignificantly different after Bonferroni–Holm correction.
bSignificantly different between sex.
cSignificantly different between diagnosis (p < 0.05).